Chemoinformaics analysis of (5E)-2,6-DIMETHYLOCTA-5,7-DIEN-2-OL
Molecular Weight | 154.253 | nRot | 4 |
Heavy Atom Molecular Weight | 136.109 | nRig | 7 |
Exact Molecular Weight | 154.136 | nRing | 0 |
Solubility: LogS | -2.941 | nHRing | 0 |
Solubility: LogP | 1.958 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 29.5043 |
nHD | 1 | BPOL | 18.0577 |
QED | 0.728 |
Synth | 1.622 |
Natural Product Likeliness | 0.075 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.437 |
Pgp-sub | 0.001 |
HIA | 0.005 |
CACO-2 | -4.512 |
MDCK | 0.0000344 |
BBB | 0.94 |
PPB | 0.423142 |
VDSS | 0.555 |
FU | 0.235233 |
CYP1A2-inh | 0.903 |
CYP1A2-sub | 0.964 |
CYP2c19-inh | 0.36 |
CYP2c19-sub | 0.9 |
CYP2c9-inh | 0.061 |
CYP2c9-sub | 0.811 |
CYP2d6-inh | 0.016 |
CYP2d6-sub | 0.865 |
CYP3a4-inh | 0.082 |
CYP3a4-sub | 0.413 |
CL | 9.199 |
T12 | 0.913 |
hERG | 0.067 |
Ames | 0.025 |
ROA | 0.017 |
SkinSen | 0.291 |
Carcinogencity | 0.03 |
EI | 0.876 |
Respiratory | 0.052 |
NR-Aromatase | 0.496 |
Antiviral | No |
Prediction | 0.94798 |